Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0151371 Methods of Forming a Porous Ceramic Shaped Article and Porous Ceramic Products
A method for making a porous, chemically bonded ceramic shaped article comprises i) providing a precursor powder mixture comprising polymer particles and a...
2017/0151370 BONE MARROW ASPIRATE ENHANCED BONE GRAFT
A method of preparing a bone graft. An osteoconductive matrix is placed in a receptacle. Bone marrow aspirate is provided that includes plasma, progenitor...
2017/0151369 MULTIPLE-LAYER IMMUNE BARRIER FOR DONOR CELLS
A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate...
2017/0151368 AUTO-POLYMERIZABLE PROSTHETIC MATERIAL AND POLYMERIZED, FRACTURE-TOUGH PROSTHETIC MATERIAL WITH INCREASED...
The subject matter of the invention is an autopolymerisable two-component prosthetic base material and a method for its production comprising A) at least one...
2017/0151367 DRY DERMAL FILLER COMPOSITIONS AND METHODS OF RECONSTITUTION
Dermal fillers are provided, particularly hyaluronic acid-based dermal fillers containing additives, for example, unstable additives, the dermal fillers being...
2017/0151366 JOINING AND/OR SEALING TISSUES THROUGH PHOTO-ACTIVATED CROSS-LINKING OF MATRIX PROTEINS
A method of joining and/or sealing tissues in a surgical procedure or medical treatment, comprising the steps of: (1) applying a matrix protein, a...
2017/0151365 HEMOSTATIC DEVICES
Hemostatic devices for promoting blood clotting can include a substrate (e.g., gauze, textile, sponge, sponge matrix, one or more fibers, etc.), a hemostatic...
2017/0151364 MULTI-COMPONENT FRAGRANCE DISPENSING APPARATUS
The present invention relates to a multi-component fragrance dispensing apparatus comprising at least an aqueous based composition and a volatile solvent based...
2017/0151362 TABLE TOP SCENT DISPENSING DEVICE AND METHOD
A method of operating a scent dispensing device includes starting operation of an air mover to move air. A motor orients a scent cartridge in a first...
2017/0151361 WICK FOR VOLATILE SUBSTANCE EVAPORATORS
The present invention relates to a wick for volatile substance evaporators formed from a strip (1) of wood and characterized in that the strip (1) has a height...
2017/0151360 DEVICE FOR EVAPORATING VOLATILE SUBSTANCES
The invention relates to a device for evaporating volatile substances, comprising a heat source (5) evaporating volatile substances from a refill (2), a heat...
2017/0151359 LIGHT DISINFECTION SYSTEM AND METHOD
A lighting system includes a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one...
2017/0151358 GARMENT SANITIZER
The invention relates to a garment sanitizing device (1, 31) comprising a housing (2), a chamber (4) within the housing to receive one or more garments (14) to...
2017/0151357 METHOD FOR TREATING RENAL CELL CARCINOMA
Accordingly, the present invention provides a method of treating kidney neoplasia in a subject in need of treatment, by subjecting the patient to SIRT.
2017/0151356 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
Disclosed herein are compositions and methods of use comprising combinations of anti-CD22 antibodies with a therapeutic agent. The therapeutic agent may be...
2017/0151355 TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER
Method of using androgen receptor and/or butyrylcholinesterase targeted radiolabeled compounds, e.g., cycloSalingenyl pyrimidine nucleoside monophosphates, for...
2017/0151354 AUGER ELECTRON THERAPY FOR GLIOBLASTOMA
A method is provided for treating or ameliorating a high-grade glioma in a patient, which method comprises intracerebral administering of a radioactive agent...
2017/0151353 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods...
2017/0151352 IMMUNOLOGICAL DETECTION OF ALTERED CELLS
Disclosed are methods, compositions of matter, and protocols useful for the detection of altered cells in a patient. Immune cells capable of clonal expansion...
2017/0151351 Gd-ENCAPSULATED CARBON DOTS AND METHODS OF MAKING AND USING THEREOF
Gd-encapsulated carbonaceous dots (Gd@C-dots) hold great potential in clinical translation as Ti contrast agent for magnetic resonance imaging. However,...
2017/0151350 PHOSPHORESCENT NANOPARTICLES AND THEIR USES IN BIOSENSING AND BIOIMAGING
Size-tunable phosphorescent particles may be formed through self-assembly of biocompatible linear polymers, such as chitosan and other linear polymers, that...
2017/0151349 PARTICLES COMPRISING PROTAMINE AND RNA IN COMBINATION WITH ENDOSOME DESTABILIZING AGENTS
The present invention relates to particles comprising protamine, RNA and at least one endosome destabilizing agent, to methods of their production and to...
2017/0151348 MYOSTATIN INHIBITION FOR ENHANCING MUSCLE AND/OR IMPROVING MUSCLE FUNCTION
The present invention relates to methods for inhibitiing myostatin, a regulator of muscle mass, for muscle enhancement (including inducing hypertrophy and/or...
2017/0151347 FUNCTIONALIZED NANOPARTICLES WITH ENCAPSULATED CARGO AND METHOD OF THEIR SELF-ASSEMBLY
This application discloses the approach of synthesizing cellulose acetate nanoparticles and rods which may have a chemically functionalized surface and an...
2017/0151346 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE
The present invention relates to novel disulfur bridge linkers containing hydrazine used for the specific conjugation of compounds/cytotoxic agents to a...
2017/0151345 COMPOSITIONS AND METHODS FOR TREATING CANCER
The technology described herein is directed to methods and compositions directed to the treatment of cancer, e.g. using multifunctional receptor targeted...
2017/0151344 ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their...
2017/0151343 ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their...
2017/0151342 TARGETED INTERFERONS DEMONSTRATE POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES
Novel chimeric moieties that show significant efficacy against cancers are provided. In certain embodiments the chimeric moieties comprise a targeting moiety...
2017/0151341 SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES
The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
2017/0151340 Conjugates Containing Hydrophilic Spacer Linkers
Described herein are compositions and methods for use in targeted drug delivery using cell receptor binding drug delivery conjugates containing hydrophilic...
2017/0151339 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, comprising conjugates of an active agent such as a therapeutic,...
2017/0151338 COMPOSITIONS OF PEGYLATED SOLUBLE TUMOR NECROSIS FACTOR RECEPTORS AND METHODS OF PREPARING
The present invention provides for improved compositions comprising a PEGsTNF-R1 which, in addition to having useful higher concentrations, demonstrate...
2017/0151337 HIGH PENETRATION COMPOSITION AND USES THEREOF
The present invention relates to compositions and uses of novel high penetration compositions or high penetration prodrugs (HPP), in particular HPPs for...
2017/0151336 COMPOUND OF GLYCOSAMINOGLYCAN AND ITS FABRICATION METHOD AS WELL AS APPLICATION
The present invention is related to a compound conjugating a drug with a glycosaminoglycan, such as hyaluronic acid (HA), where the drug is useful for the...
2017/0151335 SKIN EXTERNAL PREPARATION AND SKIN IRRITATION-REDUCING METHOD
Provided is a skin external preparation including a drug and nanometer-size molecular assemblies. The molecular assemblies contain an amphiphilic block...
2017/0151334 INJECTABLE AND IMPLANTABLE CARRIER SYSTEMS BASED ON MODIFIED POLY(DICARBOXYLIC ACID MULTI-OIL ESTERS) FOR THE...
Modified poly(dicarboxylic acid multiol esters) are suitable as carriers for bioactive substances, especially as injectable implants, without further...
2017/0151333 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF
The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and...
2017/0151332 BIOPHOTONIC MATERIALS AND USES THEREOF
The present disclosure provides biophotonic materials and methods useful in phototherapy. In particular, the biophotonic materials of the present disclosure...
2017/0151331 NANOSTARS AND NANOCONSTRUCTS FOR DETECTION, IMAGING, AND THERAPY
A polymer-free synthesis method is provided for preparation of monodisperse nanostars. The nanostars can be used for treating and imaging cells in in vivo or...
2017/0151330 ULTRASOUND DELIVERY OF NANOPARTICLES
Enhanced delivery of compositions for treatment of skin tissue with photoactive plasmonic nanoparticles and light, with embodiments relating to delivery...
2017/0151329 FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS
A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
2017/0151328 HIGH CONCENTRATION FORMULATIONS OF ANTI-C5 ANTIBODIES
The present disclosure relates to, inter alia, stable aqueous solutions comprising a high concentration of an antibody that binds to human complement component...
2017/0151327 INDUCTION OF IMMUNOTOLERANCE
The present invention provides for a novel method for inhibiting an undesirable immune response, especially in transplant recipients such as those having...
2017/0151326 IMMUNITY INDUCER
Disclosed is an immunity inducer. The immunity inducer comprises virus like particles; the virus like particles comprise a virus-derived outer coat protein and...
2017/0151325 COMPOSITIONS OF FOOD ALLERGENS
The invention relates to novel compositions and methods for diagnosing or treating food allergies. The invention particularly discloses new approaches for...
2017/0151324 Genetically Engineered Swine Influenza Virus And Uses Thereof
The present invention relates, in general, to attenuated swine influenza viruses having an impaired ability to antagonize the cellular interferon (IFN)...
2017/0151323 RECOMBINANT SWINE INFLUENZA VIRUS AND USES THEREOF
Recombinant, chimeric porcine influenza viruses are disclosed that include hemagglutinin segments from more than one influenza virus subtype. Also described...
2017/0151322 CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE
Provided herein are engineered cell lines. In some embodiments, cells of an engineered cell line have altered expression of a gene and/or altered expression of...
2017/0151321 CHIMERIC PESTIVIRUSES
The present invention relates to chimeric pestiviruses having utility as immunogenic compositions and vaccines. Also described herein are methods and kits for...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.